Immediate Impact

1 from Science/Nature 79 standout
Sub-graph 1 of 21

Citing Papers

Past, present, and future of CRISPR genome editing technologies
2024 Standout
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
8 intermediate papers

Works of Emily Tarco being referenced

Implementation of American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Recommendations in a Tertiary Care Facility Increases HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Concordance and Decreases the Number of Inconclusive Cases
2009
Implementation of American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Recommendations in a tertiary care facility increases HER2 immunohistochemistry and fluorescence in situ hybridization concordance and decreases the number of inconclusive cases.
2009
and 2 more

Author Peers

Author Last Decade Papers Cites
Emily Tarco 342 324 148 19 608
Ellen N. Spremulli 257 255 172 25 681
Rosalin Mishra 334 404 78 19 698
Dan Lu 199 452 129 16 682
Oriol Arpí 373 356 145 24 701
U Vogt 314 290 111 31 569
Fraser L. Baker 216 306 175 29 703
Lorenzo Castagnoli 397 359 159 29 704
Jaleh Fallah 199 198 212 25 564
Alexandr Kristian 272 287 177 24 631
J. Mills 289 251 172 21 667

All Works

Loading papers...

Rankless by CCL
2026